Loading…
Fierce JPM Week - In Person Agenda has ended
avatar for Angus Grant

Angus Grant

BeiGene
Chief Business Officer
Angus Grant, Ph.D. joined BeiGene in June 2020 as Chief Business Executive, bringing in more than 25 years of experience across multiple key functions in the biotech industry, including business development, alliance management, research and development, and regulatory affairs . In this role, Dr. Grant oversees corporate strategy, business development and alliance management, and helps drive external innovation and investment in other companies to guide BeiGene’s global growth strategy. Prior to joining BeiGene, Dr. Grant was the CEO of the Dementia Discovery Fund (DDF), a specialist venture capital fund focused on therapeutics for age-related dementias and neurodegenerative disease. Before that, Dr. Grant spent 12 years at Celgene (now a Bristol Myers Squibb company) serving various executive roles, including Corporate Vice President of Business Development and Vice President, Regulatory Affairs. Earlier in his career, Dr. Grant worked in business development and regulatory roles at Novartis, Merck KGaA, Rhone Poulanc-Rohrer, SmithKline Beecham, and the U.S. Food and Drug Administration’s Center for Biologics. He currently serves as the Chairman of the Board for Toronto Innovation and Acceleration Partners. Dr. Grant received a bachelor’s degree from the University of Richmond and a Ph.D. in Anatomy and Immunology from the Medical College of Virginia and completed his postdoctoral training at the National Cancer Institute.

My Speakers Sessions

  • Timezone Fierce JPM Week - In Person Agenda
    America/Los Angeles
  • Filter By Type